Join our interactive discussion with three lawyers who until recently served in senior roles in the Legal Departments of the European Medicines Agency (EMA), the Swiss Agency for Therapeutic Products (Swissmedic) and the U.S. Food and Drug Administration (FDA).
Members of Sidley’s Life Sciences team will discuss timely issues facing regulated entities before these agencies, including market access, accelerated approval, compounding, Brexit, digital health and real-world evidence.
Participants are invited to suggest any regulatory topic they would like to have discussed at this event on the registration form.
Andreas Balsiger Betts
Senior Advisor and Former Head Legal and Member of the Board of Directors, Swissmedic
Counsel and Former Legal Advisor, EMA
Rebecca K. Wood
Partner and Former Chief Counsel, FDA
The event is open to in-house counsel at life sciences companies. Feel free to forward this invitation to your in-house colleagues. There is no registration fee to attend this event. Due to space limitations for this event, registrations will be confirmed by email.